أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

 _    _    __   __   ______     _____   __    __  
| \  / ||  \ \\/ // |      \\  |  ___|| \ \\ / // 
|  \/  ||   \ ` //  |  --  //  | ||__    \ \/ //  
| .  . ||    | ||   |  --  \\  | ||__     \  //   
|_|\/|_||    |_||   |______//  |_____||    \//    
`-`  `-`     `-`'   `------`   `-----`      `